Skip to content

Post-Market Study of the 3DKnee™ System

Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00819481
Enrollment
229
Registered
2009-01-09
Start date
2009-02-28
Completion date
2018-10-31
Last updated
2021-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Joint Disease, Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis

Keywords

Total knee replacement

Brief summary

The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery.

Detailed description

Total knee replacement surgery is widely accepted as effective treatment for degenerative joint disease (DJD), osteoarthritis and rheumatoid arthritis. Relief of patient pain and return of mobility are the primary goals that can be accomplished by this surgery. The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery. The study will take place at multiple sites across the United States and be managed by the Encore Medical Clinical Affairs Department. The study will include only patients who meet the indications for use criteria for the 3DKnee™ System and who are candidates for primary knee arthroplasty.

Interventions

DEVICE3DKnee™ System

Total knee replacement joint for subjects with knee osteoarthritis and willing to participate in the study.

Sponsors

Encore Medical, L.P.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* This must be a primary knee replacement on this knee. * Patient is over 18 years of age or older * Have knee joint disease related to one or more of the following * degenerative joint disease, including osteoarthritis or traumatic arthritis * Avascular necrosis of the femoral condyles * Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy * Moderate valgus, varus, or flexion deformities * Rheumatoid arthritis * Patient is likely to be available for evaluation for the duration of the study * Able and willing to sign the informed consent and follow study procedures * Patient is not pregnant

Exclusion criteria

* Is younger than 18 years of age * If there has been a total knee replacement on this knee in the past (no revisions allowed in study) * Infection, or history of infection, acute or chronic, local or systemic * Alcoholism or other addictions * Muscular, neurological or vascular deficiencies which compromise the affected extremity * Obesity * Insufficient bone quality * Loss of ligamentous structures * High levels of physical activity * Materials sensitivity * Prisoner * Mental conditions that may interfere with the patient's ability to give an informed consent or willingness to fulfill the study requirements * Patient is pregnant

Design outcomes

Primary

MeasureTime frame
efficacy of total knee system2 year

Secondary

MeasureTime frame
change in Knee Society Score5 year
change in pain from pre-op to post-op5 year
patient satisfaction5 year
change in WOMAC Osteoarthritis Index from pre-surgery5 year
change in Oxford Knee Score from pre-surgery5 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026